| 2025 | A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B | JOURNAL OF HEPATOLOGY |
| 2025 | Robust Predictive Performance of the SALT-M Score for Clinical Outcomes in Asian Patients With Acute-on-Chronic Liver Failure | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2024 | Incidence of metabolic dysfunction-associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2024 | Epigenetic scars in regulatory T cells are retained after successful treatment of chronic hepatitis C with direct-acting antivirals | JOURNAL OF HEPATOLOGY |
| 2024 | T-Cell Dynamics Predicts Prognosis of Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2024 | A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma
| NATURE COMMUNICATIONS |
| 2024 | Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2024 | Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2024 | Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2024 | Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation | HEPATOLOGY INTERNATIONAL |
| 2024 | Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| 2024 | Advancing Korean nationwide registry for hepatocellular carcinoma: a systematic sampling approach utilizing the Korea Central Cancer Registry database | Journal of Liver Cancer(대한간암학회지) |
| 2024 | HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
| GASTROENTEROLOGY |
| 2024 | Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease | GUT AND LIVER |
| 2023 | Surveillance for hepatocellular carcinoma in non-alcoholic fatty liver disease patients: towards personalized risk stratification
| HEPATOBILIARY SURGERY AND NUTRITION |
| 2023 | Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating L-arginine production
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2023 | Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma
| CELL COMMUNICATION AND SIGNALING |
| 2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus-related liver cirrhosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B | LIVER INTERNATIONAL |
| 2023 | Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
| JHEP REPORTS |
| 2023 | The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial: A Validation Study of 2021 AASLD Practice Guidance for SBP | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2023 | Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease | LIVER INTERNATIONAL |
| 2023 | Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models
| BIOMEDICINE & PHARMACOTHERAPY |
| 2023 | Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| 2023 | Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
| DIAGNOSTICS |
| 2023 | Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
| NATURE COMMUNICATIONS |
| 2022 | Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinoma | LIVER INTERNATIONAL |
| 2022 | Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner
| JOURNAL OF HEPATOLOGY |
| 2022 | Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
| Journal of Liver Cancer(대한간암학회지) |
| 2022 | Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
| GUT AND LIVER |
| 2022 | Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model
| GASTROENTEROLOGY REPORT |
| 2022 | Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B | DIGESTIVE DISEASES AND SCIENCES |
| 2022 | Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS)
| CANCERS |
| 2022 | Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
| CANCERS |
| 2022 | Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
| JOURNAL OF HEPATOLOGY |
| 2022 | KASL clinical practice guidelines for management of chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2022 | Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
| FRONTIERS IN MEDICINE |
| 2022 | Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2022 | Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)
| CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2022 | Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study | JOURNAL OF VIRAL HEPATITIS |
| 2022 | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
| GUT AND LIVER |
| 2022 | Impaired antibacterial response of liver sinusoidal Vγ9 + Vδ2 + T cells in patients with chronic liver disease | GUT |
| 2022 | Predictors of Sarcopenia in an Obese Asian Population | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
| 2022 | A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor- β signaling
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2022 | External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
| CANCERS |
| 2022 | Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis
| DIAGNOSTICS |
| 2022 | Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL | AMERICAN JOURNAL OF GASTROENTEROLOGY |
http://orcid.org/0000-0001-6324-2224
(47861376300)
